Press esc to head back
 
2023

Year in Review

As we embrace the opportunities that 2024 holds, we take a moment to reflect on the remarkable year that was 2023—a year marked by mutual collaboration, significant growth, and numerous accomplishments.

x

Let's Recap>>

The Year in a Snapshot

Key Activities for the year

x

Q1 - FY24
Q2 - FY24
Q3 - FY24
Q4 - FY24

Project 1

Brief Description

Project 2

Brief Description

Project 1

Brief Description

Project 4

Brief Description

Successfully completed [number] projects, [number] assets, and [number] campaigns, significantly impacting [specific business areas]. 

356

10+

3 Years

Elevated key performance indicators such as Customer Experience Quotient and Digital Maturity, accelerating go-to-market strategies and realizing significant cost savings. 

 Entered a [number of years] partnership to improvise marketing in [Region] through enhanced content creation and dissemination.

In 2023, we embarked on a transformative journey, expanding our horizons and redefining marketing standards. We've ventured into new territories and forged powerful alliances, all aimed at delivering exceptional results and sustainable growth This includes areas like marketing, content creation, regulatory affairs and more. Some of the key highlights are:

 
 

Scaling 

Transformation

Scaling New Heights: Our Journey in 2023

x

We trained some of the best-in-class NLP, ML classifiers and machine vision platforms to automate the process of life sciences content modularization.

NEXT Content Management

In 2023, we are able to jointly streamline the marketing operations with our proprietary NEXT suite of solutions. Our technology classifies content and applies medical taxonomy based on therapies, audience and channel nuances to accelerate deployment and enable adoption.

 
 

Adoption of 

Latest Technology

Embracing the Future: Technology at the Forefront

x

We trained some of the best-in-class NLP, ML classifiers and machine vision platforms to automate the process of life sciences content modularization.

NEXT Patient Engagement

We trained some of the best-in-class NLP, ML classifiers and machine vision platforms to automate the process of life sciences content modularization.

NEXT Campaign Collaboration

·       Co-created solutions in [number] focusing on clinical, commercial, and data science problems.

Co-engineering 

Solutions

In 2023, we are able to jointly streamline the marketing operations with our proprietary NEXT suite of solutions. Our technology classifies content and applies medical taxonomy based on therapies, audience and channel nuances to accelerate deployment and enable adoption.

Put forward newer strategies

Joint Events Participation

 
 

Innovation

for the future

We pioneered unique engagement initiatives in [specific medical areas] for effective communication and information dissemination. 

x

·       Developed and implemented strategies and frameworks for [specific teams or products].

·       Jointly partcipated in innovative events like [] to address challenges in [specific fields or areas].

Recognized as a preferred supplier in [] with quality and reliable deliverables.

Preferred Supplier

Recognition

In 2023, we are the partners of choice leading with consultation and thought leadership. Underpinned by proprietary measurement tools and deep life sciences experience, we set your vision, inform your strategy, optimize your clinical, medical and commercial operating model, and inform technology decisions.

NPS Survey Excellence

 
 

Building the Partnership muscle

Building Stronger Bonds: Our Partnerships in 2023

x

·       Hosted key leaders from [partner company] at our centers in [cities], further cementing our innovative and strategic partnership.

Welcoming Key Leaders

·       Received invaluable feedback from [number of respondents] in our NPS survey, providing clear direction for future improvements and actions.

We are excited to continue this journey with you in 2024, striving to enhance and enrich our partnership further. 

We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the 

John Doe

Our client partners

2023 Indegene. All Rights Reserved 

We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the 

John Doe

We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the 

John Doe

We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the 

John Doe